A real-world study at MSK reveals promising efficacy and safety of second-generation BTK inhibitors in mantle cell lymphoma treatment, influencing future guidelines.
Lynnette Henshaw, PharmD, BCOP
Advertisement
Articles by Lynnette Henshaw, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Evolving Strategies for RSV Prevention in Infants
2
UB-VV111: First In Vivo CAR T Candidate Moves Forward With FDA Fast Track Designation
3
FDA Approves First Oral Targeted BTKi Treatment for Patients with Chronic Hives
4
Novel Gene Therapy Significantly Slows Progression of Huntington Disease
5
